cytarabine and pd 184352

cytarabine has been researched along with pd 184352 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andreeff, M; Carter, BZ; Estey, E; Estrov, Z; Harris, D; Konopleva, M; Kornblau, SM; Lapillonne, H; Milella, M; Zhao, S1

Other Studies

1 other study(ies) available for cytarabine and pd 184352

ArticleYear
Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia.
    The Journal of clinical investigation, 2001, Volume: 108, Issue:6

    Topics: Apoptosis; Benzamides; Cell Cycle; Cell Cycle Proteins; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Cytarabine; Enzyme Inhibitors; Flavonoids; Humans; Leukemia, Myeloid, Acute; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Proteins; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Tumor Cells, Cultured; Tumor Suppressor Proteins; X-Linked Inhibitor of Apoptosis Protein

2001